Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Run-Lin Gao

Showing results (31-40 of 308) with videos related to

Pageof 31
Sort By:
Chinese Medical Journal|December 21, 2012
Dicycloplatin differentially inhibits proliferation of human aortic smooth muscle and endothelial cells: potential for use in drug-eluting stentsLian-jun Xu, Run-lin Gao, Chao Wu, et al.
Microvascular Research|October 24, 2006
Different effects of postconditioning on myocardial no-reflow in the normal and hypercholesterolemic mini-swinesJing-Lin Zhao, Yue-Jin Yang, Shi-Jie You, et al.
Cardiovascular Drugs and Therapy|July 1, 2020
Benefit-Risk Profile of DAPT Continuation Beyond 1 Year after PCI in Patients with High Thrombotic Risk Features as Endorsed by 2018 ESC/EACTS Myocardial Revascularization GuidelineHao-Yu Wang, Ke-Fei Dou, Yang Wang, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|November 28, 2006
Patients with low high-density lipoprotein-cholesterol or smoking are more likely to develop myocardial infarction among subjects with a visible lesion or stenosis in coronary arteryYu-Hua Sun, Yue-Jin Yang, Wei-Dong Pei, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 31, 2013
First-in-man report of a novel dedicated radiofrequency catheter for renal denervation via the transulnar approachXiong-Jing Jiang, Hui Dong, Tuo Liang, et al.
The American Journal of Cardiology|August 20, 2020
Risk/Benefit Tradeoff of Prolonging Dual Antiplatelet Therapy More Than 12 Months in TWILIGHT-Like High-Risk Patients After Complex Percutaneous Coronary InterventionHao-Yu Wang, Ke-Fei Dou, Dong Yin, et al.
BMJ Open|September 14, 2022
Associated factors for discontinuation of statin use one year after discharge in patients with acute coronary syndrome in ChinaGaoqiang Xie, Phyo Kyaw Myint, Yihong Sun, et al.
BMC Cardiovascular Disorders|July 3, 2020
Contribution of ESC DAPT guideline-endorsed high thrombotic risk features to long-term clinical outcomes among patients with and without high bleeding risk after PCIHao-Yu Wang, Ke-Fei Dou, Dong Yin, et al.
Cardiovascular Therapeutics|May 15, 2020
Association of <i>β</i>-Blocker Therapy at Discharge with Clinical Outcomes after Acute Coronary Syndrome in Patients without Heart FailureYan Chen, Xiao-Fang Tang, Run-Lin Gao, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|February 5, 2010
[Plasma N-terminal pro-B-type natriuretic peptide reference value in subjects without heart diseases]Bing-Qi Wei, Yue-Jin Yang, Jian Zhang, et al.
Pageof 31

Showing results (31-40 of 308) with videos related to

Sort By:
Pageof 31
Chinese Medical Journal|December 21, 2012
Dicycloplatin differentially inhibits proliferation of human aortic smooth muscle and endothelial cells: potential for use in drug-eluting stentsLian-jun Xu, Run-lin Gao, Chao Wu, et al.
Microvascular Research|October 24, 2006
Different effects of postconditioning on myocardial no-reflow in the normal and hypercholesterolemic mini-swinesJing-Lin Zhao, Yue-Jin Yang, Shi-Jie You, et al.
Cardiovascular Drugs and Therapy|July 1, 2020
Benefit-Risk Profile of DAPT Continuation Beyond 1 Year after PCI in Patients with High Thrombotic Risk Features as Endorsed by 2018 ESC/EACTS Myocardial Revascularization GuidelineHao-Yu Wang, Ke-Fei Dou, Yang Wang, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|November 28, 2006
Patients with low high-density lipoprotein-cholesterol or smoking are more likely to develop myocardial infarction among subjects with a visible lesion or stenosis in coronary arteryYu-Hua Sun, Yue-Jin Yang, Wei-Dong Pei, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 31, 2013
First-in-man report of a novel dedicated radiofrequency catheter for renal denervation via the transulnar approachXiong-Jing Jiang, Hui Dong, Tuo Liang, et al.
The American Journal of Cardiology|August 20, 2020
Risk/Benefit Tradeoff of Prolonging Dual Antiplatelet Therapy More Than 12 Months in TWILIGHT-Like High-Risk Patients After Complex Percutaneous Coronary InterventionHao-Yu Wang, Ke-Fei Dou, Dong Yin, et al.
BMJ Open|September 14, 2022
Associated factors for discontinuation of statin use one year after discharge in patients with acute coronary syndrome in ChinaGaoqiang Xie, Phyo Kyaw Myint, Yihong Sun, et al.
BMC Cardiovascular Disorders|July 3, 2020
Contribution of ESC DAPT guideline-endorsed high thrombotic risk features to long-term clinical outcomes among patients with and without high bleeding risk after PCIHao-Yu Wang, Ke-Fei Dou, Dong Yin, et al.
Cardiovascular Therapeutics|May 15, 2020
Association of <i>β</i>-Blocker Therapy at Discharge with Clinical Outcomes after Acute Coronary Syndrome in Patients without Heart FailureYan Chen, Xiao-Fang Tang, Run-Lin Gao, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|February 5, 2010
[Plasma N-terminal pro-B-type natriuretic peptide reference value in subjects without heart diseases]Bing-Qi Wei, Yue-Jin Yang, Jian Zhang, et al.
Pageof 31